Late-stage productivity improved in 2025, but total clinical development duration rose to 10 years, indicating non-structural ...
Biological products, or biologics, are large, complex molecules produced in living systems such as therapeutic proteins, antibodies, and gene- or cell-based therapies. Under the Public Health Service ...
WHO says the initiative is part of a broader effort to strengthen global research systems, improve public trust in science, ...
In this video interview, Sam Hinsley, statistics manager at Phastar, reflects on why she chose a career in clinical trials ...
Simulations of a real-world explanatory trial of transarterial radioembolization for advanced unresectable hepatocellular carcinoma with portal vein invasion were performed to examine the effects of ...
With rising complexity in clinical trials creating additional patient burden, innovative solutions can be leveraged to mitigate risk.
A B.C.-led clinical research team is behind a study that could help improve care for critically ill patients in intensive ...
Recent Trends and Patient Outcomes of Phase I Trials: A Single-Institution Experience in the Era of New Therapeutic Agents This study reviewed all industry-sponsored phase I clinical trial protocols ...
A common thread in your work has been connecting people to clinical trials. Was that the focus in founding the CARE Research Center? The impetus behind the CARE Research Center is probably not so ...